首页> 外文OA文献 >P122 Combination therapy with inhaled salmeterol plus fluticasone propionate is more effective than salmeterol alone in reducing the risk of clinically important deterioration in COPD: A post-hoc analysis of the TORCH trial: Abstract P122 Table 1

【2h】

P122 Combination therapy with inhaled salmeterol plus fluticasone propionate is more effective than salmeterol alone in reducing the risk of clinically important deterioration in COPD: A post-hoc analysis of the TORCH trial: Abstract P122 Table 1

机译：P122用吸入的Salmeteroll加氟碳松丙酸盐的组合疗法比单独的Salmeterol更有效，以降低COPD临床重要恶化的风险：火炬试验的后HOC分析：摘要P122表1

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
I Naya; L Tombs; P Jones;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. A Dose–Response Study to Examine the Methodology for Demonstrating the Local Therapeutic Equivalence of the Fluticasone Propionate Component of an Orally Inhaled Combination Therapy of Fluticasone Propionate/Salmeterol Dry Powder [J] . Richard Allan, Scott Haughie, Edward Kerwin, Journal of aerosol medicine and pulmonary drug delivery . 2019,第6期

机译：一种剂量 - 反应研究，以研究证明氟酮丙酸盐/萨尔梅里尔干粉口服吸入治疗的丙酮酮丙酸酯组分的局部治疗等效物的方法
2. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial. [J] . Wouters EF, Postma DS, Fokkens B, Thorax: The Journal of the British Thoracic Society . 2005,第6期

机译：慢性阻塞性肺病患者从沙美特罗/氟替卡松联合治疗中撤出丙酸氟替卡松会导致立即和持续的疾病恶化：一项随机对照试验。
3. INHALED SALMETEROL/FLUTICASONE PROPIONATE IS MORE EFFECTIVE THAN FLUTICASONE PROPIONATE ALONE AT ACHIEVING WELL-CONTROLLED ASTHMA IN ASIAN PATIENTS: A POST HOC ANALYSIS OF THE GOAL STUDY [J] . Bousquet Jean, Barnes Neil, Gibbs Michael, Respirology : . 2015,第Suppla3期

机译：在亚洲患者中，良好控制哮喘后，吸入的沙美特罗/丙酸氟替卡松比丙酸氟替卡松更有效：事后研究的事后分析
4. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial [O] . E Wouters, D Postma, B Fokkens, 2005

机译：COPLD患者从沙美特罗/氟替卡松联合治疗中撤出丙酸氟替卡松导致立即和持续的疾病恶化：一项随机对照试验
5. P177 Fluticasone propionate/formoterol fumarate combination therapy is as effective as fluticasone propionate/salmeterol xinafoate in the treatment of asthma: a randomised controlled trial [O] . A. Bodzenta-Lukaszyk, A. Dymek, H. Mansikka 2010

机译：P177氟替卡松丙酸酯/福莫特罗富马酸盐联合疗法如散发物丙酸盐/萨米特蛋白在治疗哮喘：随机对照试验中有效

P122 Combination therapy with inhaled salmeterol plus fluticasone propionate is more effective than salmeterol alone in reducing the risk of clinically important deterioration in COPD: A post-hoc analysis of the TORCH trial: Abstract P122 Table 1

著录项

引文网络

相似文献

相关主题

期刊订阅